Currently, the standard monthly Medicare Part B premium is $174.70. In 2025, it's rising to $185. That's an increase of ...

Patricia Greene had spent a month recovering from a devastating stroke when her Medicare Advantage insurer, a unit of ...

Medicare Part B premiums are rising again in 2025. The jump outpaces both Social Security's 2025 COLA and inflation, further ...

Medicare's Part B monthly premium is outpacing both inflation and Social Security's cost-of-living adjustment.

In 2025, an annual $2,000 out-of-pocket cap will keep costs low for Medicare enrollees on drugs covered by Part D plans. A ...

This is bad news for folks with traditional Medicare health insurance — but not so much for those with a Medicare Advantage or drug plan. Read 6 Medicare Costs Are Set to Jump in the New Year from ...

In a focus group this past spring, seniors gave it to us straight: When you’re making an important decision like choosing ...

The majority of Medicare patients opt into Medicare Advantage programs, considering them more affordable with lower premiums.

On November 8, the Centers for Medicare and Medicaid Services announced the Medicare premiums and costs for 2025. Let’s take ...

回顾历史，Medicare是在1965年由时任总统林登·约翰逊签署成为法律的，它最初是为65岁及以上的老年人提供医疗保险。这一举措标志着美国政府在社会保障领域迈出了重要一步。随着时间的推移，Medicare逐渐扩展，涵盖了更多的人群和服务项目，如残疾人士和某些长期病患者。如今，Medicare已成为美国最大的公共医疗保险计划之一，分为Part A（住院保险）、Part B（医疗保险）、Part C ...

According to KFF research, senior citizens are presented with confusing, predatory, and misleading marketing for so-called ...

西雅图 - Adaptive Biotechnologies Corporation (NASDAQ:ADPT)今日宣布,其clonoSEQ检测获得Medicare承包商Palmetto GBA的扩大覆盖范围,将包括患有套细胞淋巴瘤(MCL)的Medicare患者。这一决定允许对这类患者进行可测量残留病变(MRD)的检测和监测。 MCL是非霍奇金淋巴瘤的一种亚型,在美国每年约有4,000例新病例。